• As a result of the dramatic shift within the pharmaceutical industry towards the rapid development of protein-based therapeutics, Malvern Instruments has embarked on an exciting and innovative program of partnership with biopharmaceutical developers and manufacturers to develop an intimate knowledge of their current and future analytical requirements. 
  • Because the methodology of manufacture, packaging, delivery and characterization of these products differs in many ways from the ‘small molecule’ paradigm, the analytical instrumentation required to serve it is also markedly different. For example, the structural complexity of the therapeutic candidate, particularly in terms of optimizing formulation conditions to enhance product efficacy, stability and manufacturability is a significant and evolving challenge. 
  • This collaborative partnership enables biopharmaceutical industry thought-leaders and Malvern Instruments to work together closely to understand industry challenges and bottlenecks, and quickly evaluate and develop technologies to address these. This presentation will discuss some of the elements of how the program operates and illustrate its key product development initiatives in this sector.